(Q40776743)

23 September 2017

Bacteriophages with potential to inactivate Salmonella Typhimurium: Use of single phage suspensions and phage cocktails (English)

1 reference

23 September 2017

1 reference

1 reference

Salmonella Typhimurium

1 reference

2

0 references

Ivonne Delgadillo

7

0 references

Adelaide Almeida

10

0 references

Jesus L. Romalde

object named as

Jésus L Romalde

8

0 references

author name string

Carla Pereira

1

1 reference

23 September 2017

Magdalena Lewicka

3

1 reference

23 September 2017

Paulo Almeida

4

1 reference

23 September 2017

Carla Clemente

5

1 reference

23 September 2017

Ângela Cunha

6

1 reference

23 September 2017

Maria L Nunes

9

1 reference

23 September 2017

25 April 2016

1 reference

23 September 2017

1 reference

23 September 2017

220

1 reference

23 September 2017

179-192

1 reference

Optimizing bacteriophage plaque fecundity

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Seasonal change in the proportion of bacterial and phytoplankton production along a salinity gradient in a shallow estuary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Photodynamic inactivation of recombinant bioluminescent Escherichia coli by cationic porphyrins under artificial and solar irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

The RAST Server: rapid annotations using subsystems technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Infrared spectroscopy of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Prevalence of Salmonella spp. in oysters in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phenotypic resistance and the dynamics of bacterial escape from phage control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Bacteriophage cocktail significantly reduces Escherichia coli O157: H7 contamination of lettuce and beef, but does not protect against recontamination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage cocktails and the future of phage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Isolation of lytic bacteriophage against Vibrio harveyi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage choice, isolation, and preparation for phage therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Molecular interaction between bacteriophage and the gram-negative cell envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Application of a bacteriophage cocktail to reduce Salmonella Typhimurium U288 contamination on pig skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010-2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Bacteriophage resistance mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Population and evolutionary dynamics of phage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Use of bacteriophage for biological control of Salmonella Enteritidis infection in chicken.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Isolation of Surfactant-Resistant Pseudomonads from the Estuarine Surface Microlayer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Foodborne and indicator bacteria in farmed molluscan shellfish before and after depuration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Efficiency of phage cocktails in the inactivation of Vibrio in aquaculture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Evaluation of the Potential of Mid-Infrared Spectroscopy to Assess the Microbiological Quality of Ham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Comparative analysis of viral pathogens and potential indicators in shellfish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella enterica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Bacteriophages with potential for inactivation of fish pathogenic bacteria: survival, host specificity and effect on bacterial community structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Seasonal variation of bacterial communities in shellfish harvesting waters: preliminary study before applying phage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Infectious outbreaks associated with bivalve shellfish consumption: a worldwide perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

The potential for marine bivalve shellfish to act as transmission vehicles for outbreaks of protozoan infections in humans: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Effects of UV radiation on the lipids and proteins of bacteria studied by mid-infrared spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Genome dynamics of Campylobacter jejuni in response to bacteriophage predation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Biological control of Aeromonas salmonicida infection in juvenile Senegalese sole (Solea senegalensis) with Phage AS-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Transcriptomic and cellular response to bacterial challenge (pathogenic Vibrio parahaemolyticus) in farmed juvenile Haliotis rufescens fed with or without probiotic diet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage therapy: facts and fiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Identification of the host determinant of two prolate-headed phages infecting Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

7 January 2021

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Toward rational control of Escherichia coli O157:H7 by a phage cocktail.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage biocontrol of enteropathogenic and Shiga toxin-producing Escherichia coli during milk fermentation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Reduction of Escherichia coli O157:H7 viability on hard surfaces by treatment with a bacteriophage mixture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Bacteriophage control of bacterial virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

Biocontrol of Escherichia coli O157 with O157-specific bacteriophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2016.04.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2016.04.020

1 reference

23 September 2017

1 reference